NSPR
InspireMD, Inc. · Healthcare
Insiders bought $322K of InspireMD, Inc. in the last 12 months
4 insiders bought on 4 days.
NSPR over the last year
Largest buyers, last 12 months
NSPR after insider buys
3 months after each buy, from the first price a copier could get.
8 buys since 2021 with 3 months of prices.
Every filing
22 insider filings since 2021, newest first
Shane Thomas Gleason · Chief Commercial Officer
Marvin Slosman · CEO and President
Paul Stuka · Director
Scott R. Ward · Director
Gary S Roubin · Director
Gary S Roubin · Director
Paul Stuka · Director
Thomas J Kester · Director
Gary S Roubin · Director
Paul Stuka · Director
Gary S Roubin · Director
Thomas J Kester · Director
Michael Berman · Director
Gary S Roubin · Director
Paul Stuka · Director
Paul Stuka · Director
Paul Stuka · Director
Gary S Roubin · Director
Gary S Roubin · Director
Gary S Roubin · Director
Thomas J Kester · Director
Michael Berman · Director
About InspireMD, Inc.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.